🎉 M&A multiples are live!
Check it out!

Camp4 Therapeutics Valuation Multiples

Discover revenue and EBITDA valuation multiples for Camp4 Therapeutics and other public comps.

See Camp4 Therapeutics Valuation Multiples

Camp4 Therapeutics Overview

About Camp4 Therapeutics

Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.


Founded

2015

HQ

United States of America
Employees

58

Website

camp4tx.com

Financials

LTM Revenue $0.2M

LTM EBITDA -$53.6M

EV

$95.0M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Camp4 Therapeutics Financials

Camp4 Therapeutics has a last 12-month revenue of $0.2M and a last 12-month EBITDA of -$53.6M.

In the most recent fiscal year, Camp4 Therapeutics achieved revenue of $0.3M and an EBITDA of -$50.2M.

Camp4 Therapeutics expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Camp4 Therapeutics valuation multiples based on analyst estimates

Camp4 Therapeutics P&L

FY 2022 FY 2023 FY 2024 LTM NTM
Revenue n/a $0.3M $0.1M $0.2M XXX
Gross Profit n/a n/a n/a XXX XXX
Gross Margin NaN% NaN% NaN% XXX XXX
EBITDA -$44.1M -$50.2M -$52.2M -$53.6M XXX
EBITDA Margin -Infinity% -14343% -35784% -35152% XXX
Net Profit n/a -$44.2M -$49.3M XXX XXX
Net Margin NaN% -12626% -33819% XXX XXX
Net Debt n/a n/a n/a XXX XXX

Financial data powered by Morningstar, Inc.

Camp4 Therapeutics Stock Performance

As of February 7, 2025, Camp4 Therapeutics's stock price is $4.

Camp4 Therapeutics has current market cap of $88.1M, and EV of $95.0M.

See Camp4 Therapeutics trading valuation data

Camp4 Therapeutics Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$95.0M $88.1M XXX XXX XXX XXX $-5.74

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Camp4 Therapeutics Valuation Multiples

As of February 7, 2025, Camp4 Therapeutics has market cap of $88.1M and EV of $95.0M.

Camp4 Therapeutics's trades at 623.5x LTM EV/Revenue multiple, and -1.8x LTM EBITDA.

Analysts estimate Camp4 Therapeutics's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Camp4 Therapeutics and 10K+ public comps

Camp4 Therapeutics Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $95.0M XXX XXX XXX
EV/Revenue 652.0x XXX XXX XXX
EV/EBITDA -1.8x XXX XXX XXX
P/E -1.7x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -1.9x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Camp4 Therapeutics Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Camp4 Therapeutics Valuation Multiples

Camp4 Therapeutics's NTM/LTM revenue growth is 22%

Camp4 Therapeutics's revenue per employee for the last fiscal year averaged $6K, while opex per employee averaged $0.9M for the same period.

Over next 12 months, Camp4 Therapeutics's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Camp4 Therapeutics's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Camp4 Therapeutics and other 10K+ public comps

Camp4 Therapeutics Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -58% XXX XXX XXX XXX
EBITDA Margin -35784% XXX XXX XXX XXX
EBITDA Growth 4% XXX XXX XXX XXX
Rule of 40 (SaaS-only) -35762% XXX XXX XXX XXX
Revenue per Employee $6K XXX XXX XXX XXX
Opex per Employee $0.9M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue 3318% XXX XXX XXX XXX
R&D Expenses to Revenue 11605% XXX XXX XXX XXX
Opex to Revenue 14923% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Medical Devices
Consumer SaaS
Streaming Platforms
AdTech Software
Climate Tech
GRC Software
Developer Tools

Camp4 Therapeutics Public Comps

See valuation multiples for Camp4 Therapeutics public comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Camp4 Therapeutics M&A and Investment Activity

Camp4 Therapeutics acquired  XXX companies to date.

Last acquisition by Camp4 Therapeutics was  XXXXXXXX, XXXXX XXXXX XXXXXX . Camp4 Therapeutics acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Camp4 Therapeutics

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Camp4 Therapeutics

When was Camp4 Therapeutics founded? Camp4 Therapeutics was founded in 2015.
Where is Camp4 Therapeutics headquartered? Camp4 Therapeutics is headquartered in United States of America.
How many employees does Camp4 Therapeutics have? As of today, Camp4 Therapeutics has 58 employees.
Who is the CEO of Camp4 Therapeutics? Camp4 Therapeutics's CEO is Mr. Joshua Mandel-Brehm.
Is Camp4 Therapeutics publicy listed? Yes, Camp4 Therapeutics is a public company listed on NAS.
What is the stock symbol of Camp4 Therapeutics? Camp4 Therapeutics trades under CAMP ticker.
When did Camp4 Therapeutics go public? Camp4 Therapeutics went public in 2024.
Who are competitors of Camp4 Therapeutics? Similar companies to Camp4 Therapeutics include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics.
What is the current market cap of Camp4 Therapeutics? Camp4 Therapeutics's current market cap is $88.1M
What is the current revenue of Camp4 Therapeutics? Camp4 Therapeutics's last 12-month revenue is $0.2M.
What is the current EBITDA of Camp4 Therapeutics? Camp4 Therapeutics's last 12-month EBITDA is -$53.6M.
What is the current EV/Revenue multiple of Camp4 Therapeutics? Current revenue multiple of Camp4 Therapeutics is 623.5x.
What is the current EV/EBITDA multiple of Camp4 Therapeutics? Current EBITDA multiple of Camp4 Therapeutics is -1.8x.
What is the current revenue growth of Camp4 Therapeutics? Camp4 Therapeutics revenue growth between 2023 and 2024 was -58%.
Is Camp4 Therapeutics profitable? Yes, Camp4 Therapeutics is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.